These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 15926135)

  • 1. [Clinical experiences with pregabalin in the treatment of focal epilepsies].
    Gil-Nagel Rein A; Gómez-Alonso J
    Rev Neurol; 2005 May 16-31; 40(10):609-13. PubMed ID: 15926135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of two pregabalin regimens for add-on treatment of partial epilepsy.
    Beydoun A; Uthman BM; Kugler AR; Greiner MJ; Knapp LE; Garofalo EA;
    Neurology; 2005 Feb; 64(3):475-80. PubMed ID: 15699378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregabalin add-on treatment in patients with partial seizures: a novel evaluation of flexible-dose and fixed-dose treatment in a double-blind, placebo-controlled study.
    Elger CE; Brodie MJ; Anhut H; Lee CM; Barrett JA
    Epilepsia; 2005 Dec; 46(12):1926-36. PubMed ID: 16393158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregabalin or placebo used adjunctively with levetiracetam in refractory partial-onset epilepsy: a post hoc efficacy and safety analysis in combined clinical trials.
    Uthman BM; Almas M; Emir B; Giordano S; Leon T
    Curr Med Res Opin; 2011 Jul; 27(7):1285-93. PubMed ID: 21561392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregabalin: a new antiepileptic drug for refractory epilepsy.
    Hamandi K; Sander JW
    Seizure; 2006 Mar; 15(2):73-8. PubMed ID: 16413993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregabalin as adjunctive therapy for partial seizures.
    Brodie MJ
    Epilepsia; 2004; 45 Suppl 6():19-27. PubMed ID: 15315512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregabalin: a novel gamma-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disorders.
    Tassone DM; Boyce E; Guyer J; Nuzum D
    Clin Ther; 2007 Jan; 29(1):26-48. PubMed ID: 17379045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pregabalin: new drug. Very similar to gabapentin.
    Prescrire Int; 2005 Dec; 14(80):203-6. PubMed ID: 16397976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term add-on pregabalin treatment in patients with partial-onset epilepsy: pooled analysis of open-label clinical trials.
    Uthman BM; Bazil CW; Beydoun A; Schulze-Bonhage A; Benabou R; Whalen E; Emir B; Griesing T; Leon T
    Epilepsia; 2010 Jun; 51(6):968-78. PubMed ID: 20345940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Add-on treatment with pregabalin for partial seizures with or without generalisation: pooled data analysis of four randomised placebo-controlled trials.
    Gil-Nagel A; Zaccara G; Baldinetti F; Leon T
    Seizure; 2009 Apr; 18(3):184-92. PubMed ID: 18951818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of pregabalin in partial epilepsy.
    Beydoun A; Nasreddine W; Atweh S
    Expert Rev Neurother; 2008 Jul; 8(7):1013-24. PubMed ID: 18590472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of add-on therapy with pregabalin in patients with refractory partial epilepsy.
    Vera-Llonch M; Brandenburg NA; Oster G
    Epilepsia; 2008 Mar; 49(3):431-7. PubMed ID: 17822431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregabalin add-on therapy using a flexible, optimized dose schedule in refractory partial epilepsies: a double-blind, randomized, placebo-controlled, multicenter trial.
    Lee BI; Yi S; Hong SB; Kim MK; Lee SA; Lee SK; Shin DJ; Kim JM; Song HK; Heo K; Lowe W; Leon T
    Epilepsia; 2009 Mar; 50(3):464-74. PubMed ID: 19222545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-response trial of pregabalin adjunctive therapy in patients with partial seizures.
    French JA; Kugler AR; Robbins JL; Knapp LE; Garofalo EA
    Neurology; 2003 May; 60(10):1631-7. PubMed ID: 12771254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of background antiepileptic drugs on the efficacy and safety of pregabalin in treating partial-onset seizures: a post hoc analysis of combined clinical trials.
    Tomson T; Almas M; Giordano S; Cabrera J
    Epilepsy Res; 2011 Sep; 96(1-2):64-73. PubMed ID: 21624821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of secondarily generalized tonic-clonic (SGTC) seizures with pregabalin.
    Briggs DE; Lee CM; Spiegel K; French JA
    Epilepsy Res; 2008 Nov; 82(1):86-92. PubMed ID: 18752932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregabalin add-on for drug-resistant partial epilepsy.
    Lozsadi D; Hemming K; Marson AG
    Cochrane Database Syst Rev; 2008 Jan; (1):CD005612. PubMed ID: 18254084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study.
    Moon DE; Lee DI; Lee SC; Song SO; Yoon DM; Yoon MH; Kim HK; Lee YW; Kim C; Lee PB
    Clin Ther; 2010 Dec; 32(14):2370-85. PubMed ID: 21353106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety, tolerability, and pharmacokinetics of pregabalin in children with refractory partial seizures: a phase 1, randomized controlled study.
    Mann D; Liu J; Chew ML; Bockbrader H; Alvey CW; Zegarac E; Pellock J; Pitman VW
    Epilepsia; 2014 Dec; 55(12):1934-43. PubMed ID: 25377429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic and pharmacodynamic profile of pregabalin and its role in the treatment of epilepsy.
    Schulze-Bonhage A
    Expert Opin Drug Metab Toxicol; 2013 Jan; 9(1):105-15. PubMed ID: 23205518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.